Article metrics

Download PDFPDF

Effectiveness, treatment durability, and treatment costs of canagliflozin and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes in the USA

 

Online download statistics by month:

Online download statistics by month: November 2019 to January 2023

AbstractFullPdf
Nov 2019285266135
Dec 2019132130109
Jan 2020918839
Feb 2020696820
Mar 2020605825
Apr 202010810520
May 2020534731
Jun 2020525026
Jul 2020403816
Aug 2020282833
Sep 2020898339
Oct 2020717224
Nov 2020676031
Dec 2020535124
Jan 2021666630
Feb 2021636223
Mar 2021626025
Apr 2021484624
May 2021504811
Jun 2021505024
Jul 2021616117
Aug 2021393825
Sep 2021514615
Oct 2021423831
Nov 2021494721
Dec 202141399
Jan 2022373711
Feb 202233329
Mar 2022504811
Apr 2022667016
May 2022728018
Jun 202244429
Jul 202229295
Aug 202241416
Sep 2022252616
Oct 2022444216
Nov 2022545318
Dec 2022424519
Jan 2023494816
Total24062338997